Susan R Heckbert

Author PubWeight™ 356.46‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 2011 13.25
2 Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003 10.06
3 Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann Epidemiol 2003 8.64
4 Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007 6.63
5 Genomewide association studies of stroke. N Engl J Med 2009 5.29
6 Common variants at ten loci influence QT interval duration in the QTGEN Study. Nat Genet 2009 5.20
7 Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet 2009 4.56
8 Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med 2004 4.38
9 Antibiotic use in relation to the risk of breast cancer. JAMA 2004 4.28
10 Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet 2010 3.97
11 Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative. Arch Intern Med 2006 3.91
12 Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. Nat Genet 2009 3.80
13 Genome-wide association study of PR interval. Nat Genet 2010 3.73
14 Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet 2012 3.71
15 Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nat Genet 2010 3.55
16 Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop. Circulation 2009 3.50
17 Association of genetic variations with nonfatal venous thrombosis in postmenopausal women. JAMA 2007 3.50
18 Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med 2002 3.15
19 New gene functions in megakaryopoiesis and platelet formation. Nature 2011 3.14
20 Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe Project. PLoS Genet 2011 3.07
21 Depression and advanced complications of diabetes: a prospective cohort study. Diabetes Care 2009 3.06
22 Validation of an atrial fibrillation risk algorithm in whites and African Americans. Arch Intern Med 2010 3.05
23 Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). Am J Med 2002 3.04
24 Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet 2011 3.03
25 Genetic associations with valvular calcification and aortic stenosis. N Engl J Med 2013 3.02
26 Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol 2005 2.92
27 Candidate gene association resource (CARe): design, methods, and proof of concept. Circ Cardiovasc Genet 2010 2.91
28 Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007. Circ Cardiovasc Qual Outcomes 2012 2.61
29 Prediction of critical illness during out-of-hospital emergency care. JAMA 2010 2.60
30 Beta2-adrenergic receptor genetic variants and risk of sudden cardiac death. Circulation 2006 2.57
31 Left ventricular concentric remodeling is associated with decreased global and regional systolic function: the Multi-Ethnic Study of Atherosclerosis. Circulation 2005 2.54
32 Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2003 2.49
33 Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc 2013 2.47
34 Risk of new-onset atrial fibrillation in relation to body mass index. Arch Intern Med 2006 2.45
35 Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood 2002 2.41
36 Depression and increased mortality in diabetes: unexpected causes of death. Ann Fam Med 2009 2.37
37 Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium. Ann Neurol 2011 2.37
38 A systematic review of validated methods for identifying atrial fibrillation using administrative data. Pharmacoepidemiol Drug Saf 2012 2.17
39 Glucose, blood pressure, and lipid control in older people with and without diabetes mellitus: the Cardiovascular Health Study. J Am Geriatr Soc 2002 2.13
40 Genetic variants associated with cardiac structure and function: a meta-analysis and replication of genome-wide association data. JAMA 2009 2.10
41 Predictors of hospital mortality in a population-based cohort of patients with acute lung injury. Crit Care Med 2008 2.09
42 Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology. Blood 2009 2.07
43 Congestive heart failure incidence and prognosis: case identification using central adjudication versus hospital discharge diagnoses. Ann Epidemiol 2005 2.03
44 Newly detected atrial fibrillation and compliance with antithrombotic guidelines. Arch Intern Med 2007 2.00
45 N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study. Circulation 2009 1.99
46 Survival associated with two sets of diagnostic criteria for congestive heart failure. Am J Epidemiol 2004 1.99
47 Meta-analysis of genome-wide association studies from the CHARGE consortium identifies common variants associated with carotid intima media thickness and plaque. Nat Genet 2011 1.92
48 Independent susceptibility markers for atrial fibrillation on chromosome 4q25. Circulation 2010 1.90
49 European ancestry as a risk factor for atrial fibrillation in African Americans. Circulation 2010 1.90
50 A prospective study of venous thromboembolism in relation to factor V Leiden and related factors. Blood 2002 1.86
51 A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older women. Am J Epidemiol 2004 1.85
52 Association of combinations of lipid parameters with carotid intima-media thickness and coronary artery calcium in the MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2010 1.85
53 Association of genome-wide variation with the risk of incident heart failure in adults of European and African ancestry: a prospective meta-analysis from the cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium. Circ Cardiovasc Genet 2010 1.83
54 Chronic kidney disease increases risk for venous thromboembolism. J Am Soc Nephrol 2007 1.80
55 Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes. Diabetes Care 2006 1.78
56 Atrial fibrillation and the risk of sudden cardiac death: the atherosclerosis risk in communities study and cardiovascular health study. JAMA Intern Med 2013 1.74
57 Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. Am J Epidemiol 2002 1.73
58 Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders. Nat Genet 2013 1.72
59 Atrial fibrillation and cognitive decline: a longitudinal cohort study. Neurology 2013 1.71
60 Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis. JAMA 2004 1.70
61 Serum lipid levels and the risk of venous thrombosis. Arterioscler Thromb Vasc Biol 2004 1.69
62 Diabetes and poor disease control: is comorbid depression associated with poor medication adherence or lack of treatment intensification? Psychosom Med 2009 1.69
63 Genome-wide association analysis identifies multiple loci related to resting heart rate. Hum Mol Genet 2010 1.67
64 Fasting and 2-hour postchallenge serum glucose measures and risk of incident cardiovascular events in the elderly: the Cardiovascular Health Study. Arch Intern Med 2002 1.63
65 Therapy with hydroxymethylglutaryl coenzyme a reductase inhibitors (statins) and associated risk of incident cardiovascular events in older adults: evidence from the Cardiovascular Health Study. Arch Intern Med 2002 1.61
66 Myocardial infarction and stroke associated with diuretic based two drug antihypertensive regimens: population based case-control study. BMJ 2010 1.58
67 Four novel Loci (19q13, 6q24, 12q24, and 5q14) influence the microcirculation in vivo. PLoS Genet 2010 1.57
68 Time trends in high blood pressure control and the use of antihypertensive medications in older adults: the Cardiovascular Health Study. Arch Intern Med 2002 1.56
69 Association of plasma phospholipid long-chain ω-3 fatty acids with incident atrial fibrillation in older adults: the cardiovascular health study. Circulation 2012 1.54
70 Weight loss, muscle strength, and angiotensin-converting enzyme inhibitors in older adults with congestive heart failure or hypertension. J Am Geriatr Soc 2005 1.54
71 Genome-wide association studies of the PR interval in African Americans. PLoS Genet 2011 1.53
72 Depression and diabetes: factors associated with major depression at five-year follow-up. Psychosomatics 2009 1.53
73 Estrogen therapy and risk of cardiovascular events among women with type 2 diabetes. Diabetes Care 2003 1.52
74 Genome-wide joint meta-analysis of SNP and SNP-by-smoking interaction identifies novel loci for pulmonary function. PLoS Genet 2012 1.52
75 Prospective study of the G20210A polymorphism in the prothrombin gene, plasma prothrombin concentration, and incidence of venous thromboembolism. Am J Hematol 2002 1.51
76 Diabetes mellitus, glycemic control, and risk of atrial fibrillation. J Gen Intern Med 2010 1.50
77 Esterified estrogen and conjugated equine estrogen and the risk of incident myocardial infarction and stroke. Arch Intern Med 2006 1.50
78 Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction. Am J Respir Crit Care Med 2012 1.49
79 Comorbid depression is associated with an increased risk of dementia diagnosis in patients with diabetes: a prospective cohort study. J Gen Intern Med 2010 1.48
80 Supplemental oxygen causes increased signal intensity in subarachnoid cerebrospinal fluid on brain FLAIR MR images obtained in children during general anesthesia. Radiology 2004 1.47
81 Genome-wide association studies of MRI-defined brain infarcts: meta-analysis from the CHARGE Consortium. Stroke 2009 1.47
82 Atrial fibrillation among Medicare beneficiaries hospitalized with sepsis: incidence and risk factors. Am Heart J 2013 1.43
83 Use of Medicare data to identify coronary heart disease outcomes in the Women's Health Initiative. Circ Cardiovasc Qual Outcomes 2014 1.41
84 Acute lung injury in patients with subarachnoid hemorrhage: incidence, risk factors, and outcome. Crit Care Med 2006 1.40
85 Body size adjustments for left ventricular mass by cardiovascular magnetic resonance and their impact on left ventricular hypertrophy classification. Int J Cardiovasc Imaging 2010 1.35
86 Cerivastatin, genetic variants, and the risk of rhabdomyolysis. Pharmacogenet Genomics 2011 1.34
87 Outcomes of Medicare beneficiaries undergoing catheter ablation for atrial fibrillation. Circulation 2012 1.32
88 Statin use and breast cancer risk in a large population-based setting. Cancer Epidemiol Biomarkers Prev 2007 1.31
89 The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study. Cancer 2004 1.31
90 The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension: the cardiovascular health study. Am J Kidney Dis 2004 1.31
91 Smoking status and risk for recurrent coronary events after myocardial infarction. Ann Intern Med 2002 1.27
92 Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease. Mov Disord 2006 1.27
93 The relationship between changes in depression symptoms and changes in health risk behaviors in patients with diabetes. Int J Geriatr Psychiatry 2010 1.25
94 Diuretic therapy, the alpha-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension. JAMA 2002 1.23
95 Sex hormone levels and subclinical atherosclerosis in postmenopausal women: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2008 1.22
96 Hormone replacement therapy and associated risk of stroke in postmenopausal women. Arch Intern Med 2002 1.22
97 Atrial ectopy as a predictor of incident atrial fibrillation: a cohort study. Ann Intern Med 2013 1.21
98 Modestly elevated glucose levels during pregnancy are associated with a higher risk of future diabetes among women without gestational diabetes mellitus. Diabetes Care 2008 1.20
99 Atrial fibrillation and risk of dementia: a prospective cohort study. J Am Geriatr Soc 2011 1.18
100 Echocardiographic diastolic parameters and risk of atrial fibrillation: the Cardiovascular Health Study. Eur Heart J 2011 1.17
101 Association of major depression and mortality in Stage 5 diabetic chronic kidney disease. Gen Hosp Psychiatry 2010 1.17
102 Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thrombosis. Blood 2010 1.17
103 N-terminal pro-B-type natriuretic peptide as a predictor of incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis: the effects of age, sex and ethnicity. Heart 2013 1.16
104 Logic regression for analysis of the association between genetic variation in the renin-angiotensin system and myocardial infarction or stroke. Am J Epidemiol 2006 1.15
105 Racial differences in the incidence of and risk factors for atrial fibrillation in older adults: the cardiovascular health study. J Am Geriatr Soc 2013 1.14
106 Association between cardiovascular disease risk factors and occurrence of venous thromboembolism. A time-dependent analysis. Thromb Haemost 2012 1.13
107 Use of administrative data to estimate the incidence of statin-related rhabdomyolysis. JAMA 2012 1.12
108 Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation. Circulation 2014 1.11
109 Conjugated equine estrogens and peripheral arterial disease risk: the Women's Health Initiative. Am Heart J 2006 1.10
110 Common variation in cytochrome P450 epoxygenase genes and the risk of incident nonfatal myocardial infarction and ischemic stroke. Pharmacogenet Genomics 2008 1.09
111 Matrix metalloproteinase-3 (MMP3) and MMP9 genes and risk of myocardial infarction, ischemic stroke, and hemorrhagic stroke. Atherosclerosis 2008 1.08
112 High-density lipoprotein cholesterol and venous thromboembolism in the Longitudinal Investigation of Thromboembolism Etiology (LITE). Blood 2008 1.07
113 Large-scale candidate gene analysis in whites and African Americans identifies IL6R polymorphism in relation to atrial fibrillation: the National Heart, Lung, and Blood Institute's Candidate Gene Association Resource (CARe) project. Circ Cardiovasc Genet 2011 1.06
114 Influenza vaccination is not associated with a reduction in the risk of recurrent coronary events. Am J Epidemiol 2002 1.06
115 Variation in eicosanoid genes, non-fatal myocardial infarction and ischemic stroke. Atherosclerosis 2008 1.05
116 The impact of height on the risk of atrial fibrillation: the Cardiovascular Health Study. Eur Heart J 2012 1.05
117 Variation in inflammation-related genes and risk of incident nonfatal myocardial infarction or ischemic stroke. Atherosclerosis 2007 1.05
118 The relationship between exercise and risk of venous thrombosis in elderly people. J Am Geriatr Soc 2008 1.05
119 Reference ranges of PR duration and P-wave indices in individuals free of cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA). J Electrocardiol 2013 1.04
120 Multiethnic genome-wide association study of cerebral white matter hyperintensities on MRI. Circ Cardiovasc Genet 2015 1.03
121 Higher levels of inflammation factors and greater insulin resistance are independently associated with higher heart rate and lower heart rate variability in normoglycemic older individuals: the Cardiovascular Health Study. J Am Geriatr Soc 2008 1.03
122 Angiotensin II type 1 receptor polymorphisms in the cardiovascular health study: relation to blood pressure, ethnicity, and cardiovascular events. Am J Hypertens 2002 1.02
123 OATP1B1-related drug-drug and drug-gene interactions as potential risk factors for cerivastatin-induced rhabdomyolysis. Pharmacogenet Genomics 2013 1.02
124 Prehospital systolic blood pressure thresholds: a community-based outcomes study. Acad Emerg Med 2013 1.02
125 Calcium channel blockers and beta-blockers in relation to Parkinson's disease. Parkinsonism Relat Disord 2006 1.00
126 Cholesterol ester transfer protein, interleukin-8, peroxisome proliferator activator receptor alpha, and Toll-like receptor 4 genetic variations and risk of incident nonfatal myocardial infarction and ischemic stroke. Am J Cardiol 2008 1.00
127 Predictors of subsequent coronary events, stroke, and death among survivors of first hospitalized myocardial infarction. J Clin Epidemiol 2002 1.00
128 Influenza vaccination and risk of incident myocardial infarction. Hum Vaccin 2006 0.99
129 Genetics of coronary artery calcification among African Americans, a meta-analysis. BMC Med Genet 2013 0.99
130 Biomarkers of inflammation and hemostasis associated with left ventricular mass: The Multiethnic Study of Atherosclerosis (MESA). Int J Mol Epidemiol Genet 2011 0.98
131 Prehospital intravenous access and fluid resuscitation in severe sepsis: an observational cohort study. Crit Care 2014 0.98
132 APOM and high-density lipoprotein cholesterol are associated with lung function and per cent emphysema. Eur Respir J 2013 0.97
133 Depression and incident diabetic foot ulcers: a prospective cohort study. Am J Med 2010 0.97
134 Novel loci associated with PR interval in a genome-wide association study of 10 African American cohorts. Circ Cardiovasc Genet 2012 0.97
135 Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke. Eur Heart J 2013 0.97
136 Plasma free fatty acids and risk of atrial fibrillation (from the Cardiovascular Health Study). Am J Cardiol 2012 0.97
137 Serum homocysteine, thermolabile variant of methylene tetrahydrofolate reductase (MTHFR), and venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology (LITE). Am J Hematol 2003 0.96
138 Predicting stroke through genetic risk functions: the CHARGE Risk Score Project. Stroke 2014 0.96
139 "Opioid creep" is real and may be the cause of "fluid creep". Burns 2004 0.95
140 Multi-ethnic study of atherosclerosis: association between left atrial function using tissue tracking from cine MR imaging and myocardial fibrosis. Radiology 2014 0.95
141 Prevalence of asthma and chronic respiratory symptoms among Alaska Native children. Chest 2004 0.95
142 Association of genetic variation in serum amyloid-A with cardiovascular disease and interactions with IL6, IL1RN, IL1beta and TNF genes in the Cardiovascular Health Study. J Atheroscler Thromb 2009 0.95
143 Association of genome-wide variation with highly sensitive cardiac troponin-T levels in European Americans and Blacks: a meta-analysis from atherosclerosis risk in communities and cardiovascular health studies. Circ Cardiovasc Genet 2012 0.94
144 Prospective study of fibrinolytic markers and venous thromboembolism. J Clin Epidemiol 2003 0.94
145 Impact of ancestry and common genetic variants on QT interval in African Americans. Circ Cardiovasc Genet 2012 0.94
146 Aortic valve calcium independently predicts coronary and cardiovascular events in a primary prevention population. JACC Cardiovasc Imaging 2012 0.94
147 Intake of long-chain ω-3 fatty acids from diet and supplements in relation to mortality. Am J Epidemiol 2014 0.93
148 Fasting and post-glucose load measures of insulin resistance and risk of ischemic stroke in older adults. Stroke 2011 0.93
149 Strategies to design and analyze targeted sequencing data: cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Targeted Sequencing Study. Circ Cardiovasc Genet 2014 0.93
150 The QT interval and risk of incident atrial fibrillation. Heart Rhythm 2013 0.93
151 beta1- and beta2-adrenergic receptor gene variation, beta-blocker use and risk of myocardial infarction and stroke. Am J Hypertens 2008 0.91
152 Lack of association of soluble endothelial protein C receptor and PROCR 6936A/G polymorphism with the risk of venous thromboembolism in a prospective study. Br J Haematol 2009 0.91
153 beta(2)-Adrenergic receptor polymorphisms and determinants of cardiovascular risk: the Cardiovascular Health Study. Am J Hypertens 2005 0.91
154 Combined hyperlipidemia in relation to race/ethnicity, obesity, and insulin resistance in the Multi-Ethnic Study of Atherosclerosis. Metabolism 2009 0.91
155 Association of body mass index, diabetes, hypertension, and blood pressure levels with risk of permanent atrial fibrillation. J Gen Intern Med 2012 0.90
156 Antidepressant use and breast cancer risk. Breast Cancer Res Treat 2005 0.90
157 Frailty and risk of venous thromboembolism in older adults. J Gerontol A Biol Sci Med Sci 2007 0.90
158 Chronic kidney disease and venous thromboembolism: a prospective study. Nephrol Dial Transplant 2010 0.89
159 Sex-specific association of age with carotid artery distensibility: multi-ethnic study of atherosclerosis. J Womens Health (Larchmt) 2012 0.89
160 Genome-wide study identifies two loci associated with lung function decline in mild to moderate COPD. Hum Genet 2012 0.88
161 Association of blood pressure and aortic distensibility with P wave indices and PR interval: the multi-ethnic study of atherosclerosis (MESA). J Electrocardiol 2013 0.88
162 The association of alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism in the LITE study. Thromb Res 2007 0.87
163 Genome-wide association study of cardiac structure and systolic function in African Americans: the Candidate Gene Association Resource (CARe) study. Circ Cardiovasc Genet 2012 0.87
164 The association of restrained eating with weight change over time in a community-based sample of twins. Obesity (Silver Spring) 2010 0.87
165 Angiotensinogen Met235Thr polymorphism, angiotensin-converting enzyme inhibitor therapy, and the risk of nonfatal stroke or myocardial infarction in hypertensive patients. Am J Hypertens 2003 0.87
166 Ascertainment of warfarin and aspirin use by medical record review compared with automated pharmacy data. Pharmacoepidemiol Drug Saf 2010 0.87
167 Gestational diabetes or lesser degrees of glucose intolerance and risk of preeclampsia. Hypertens Pregnancy 2010 0.87
168 Effects of respiratory and non-respiratory factors on disability among older adults with airway obstruction: the Cardiovascular Health Study. COPD 2013 0.87
169 Renin-angiotensin system haplotypes and the risk of myocardial infarction and stroke in pharmacologically treated hypertensive patients. Am J Epidemiol 2007 0.86
170 Risk of epithelial ovarian cancer in relation to use of antidepressants, benzodiazepines, and other centrally acting medications. Cancer Causes Control 2002 0.86
171 Cerivastatin in vitro metabolism by CYP2C8 variants found in patients experiencing rhabdomyolysis. Pharmacogenet Genomics 2010 0.85
172 Hypothesis: is antibiotic use associated with breast cancer? Cancer Causes Control 2003 0.85
173 Lipid-lowering drug use and cardiovascular events after myocardial infarction. Ann Pharmacother 2002 0.84
174 Total tissue factor pathway inhibitor and venous thrombosis. The Longitudinal Investigation of Thromboembolism Etiology. Thromb Haemost 2010 0.84
175 Multiple imputation for missing with cardiac magnetic resonance imaging data: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Can J Cardiol 2009 0.84
176 Longer legs are associated with greater risk of incident venous thromboembolism independent of total body height. The Longitudinal Study of Thromboembolism Etiology (LITE). Thromb Haemost 2011 0.84
177 Genetic variants of coagulation factor XIII, postmenopausal estrogen therapy, and risk of nonfatal myocardial infarction. Blood 2002 0.84
178 How does change in depressive symptomatology influence weight change in patients with diabetes? Observational results from the Pathways longitudinal cohort. J Gerontol A Biol Sci Med Sci 2009 0.84
179 Serum albumin and risk of venous thromboembolism. Thromb Haemost 2010 0.84
180 Associations of plasma phospholipid and dietary alpha linolenic acid with incident atrial fibrillation in older adults: the Cardiovascular Health Study. J Am Heart Assoc 2013 0.83
181 Genome-wide association study of L-arginine and dimethylarginines reveals novel metabolic pathway for symmetric dimethylarginine. Circ Cardiovasc Genet 2014 0.83
182 Prospective study of polymorphisms of the protein Z-dependent protease inhibitor and risk of venous thromboembolism. Thromb Haemost 2007 0.83
183 Calcium channel blocker use and gastrointestinal tract bleeding among older adults. Age Ageing 2002 0.82
184 Risk factors for hospitalized upper or lower gastrointestinal tract bleeding in treated hypertensives. Prev Med 2002 0.82
185 Blood pressure level and outcomes in adults aged 65 and older with prior ischemic stroke. J Am Geriatr Soc 2006 0.82
186 Validity of Self-Reported Medication Use Compared With Pharmacy Records in a Cohort of Older Women: Findings From the Women's Health Initiative. Am J Epidemiol 2016 0.81
187 ADAM19 and HTR4 variants and pulmonary function: Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Targeted Sequencing Study. Circ Cardiovasc Genet 2014 0.81
188 Sequencing of SCN5A identifies rare and common variants associated with cardiac conduction: Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium. Circ Cardiovasc Genet 2014 0.81
189 Hormone replacement therapy and the risk of incident congestive heart failure: the Cardiovascular Health Study. J Womens Health (Larchmt) 2003 0.81
190 Evidence of heterogeneity by race/ethnicity in genetic determinants of QT interval. Epidemiology 2014 0.81
191 Discovering novel risk factors for venous thrombosis: a candidate-gene approach. Thromb Res 2009 0.81
192 Interaction between fibrinogen and IL-6 genetic variants and associations with cardiovascular disease risk in the Cardiovascular Health Study. Ann Hum Genet 2010 0.81
193 Statistical approaches to group sequential monitoring of postmarket safety surveillance data: current state of the art for use in the Mini-Sentinel pilot. Pharmacoepidemiol Drug Saf 2012 0.81
194 Association of Sleep Apnea and Snoring With Incident Atrial Fibrillation in the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol 2015 0.80
195 Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal ischemic stroke in postmenopausal women. Arterioscler Thromb Vasc Biol 2002 0.80
196 The association of the QT interval with atrial fibrillation and stroke: the Multi-Ethnic Study of Atherosclerosis. Clin Res Cardiol 2015 0.80
197 Genetic variants related to height and risk of atrial fibrillation: the cardiovascular health study. Am J Epidemiol 2014 0.80
198 Conjugated equine estrogen, esterified estrogen, prothrombotic variants, and the risk of venous thrombosis in postmenopausal women. Arterioscler Thromb Vasc Biol 2006 0.80
199 Troponin T, NT-proBNP, and venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). Vasc Med 2014 0.79
200 Common genetic variation in six lipid-related and statin-related genes, statin use and risk of incident nonfatal myocardial infarction and stroke. Pharmacogenet Genomics 2008 0.79
201 The effect of calcium plus vitamin D supplementation on the risk of venous thromboembolism. From the Women's Health Initiative Randomized Controlled Trial. Thromb Haemost 2015 0.79
202 Lipoprotein-associated phospholipase A2 and risk of venous thrombosis in older adults. Am J Hematol 2008 0.79
203 Association of beta-blocker use with mortality among patients with congestive heart failure in the Cardiovascular Health Study (CHS). Am Heart J 2005 0.78
204 Amount of leisure-time physical activity and risk of nonfatal myocardial infarction. Ann Epidemiol 2007 0.78
205 Measures of Body Size and Composition and Risk of Incident Atrial Fibrillation in Older People: The Cardiovascular Health Study. Am J Epidemiol 2016 0.78
206 Reproductive history, hormone replacement, and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology. Br J Haematol 2010 0.78
207 Short-term and long-term risk of incident ischemic stroke after transient ischemic attack. Stroke 2009 0.78
208 Neuropathologic changes associated with atrial fibrillation in a population-based autopsy cohort. J Gerontol A Biol Sci Med Sci 2013 0.78
209 Smoking, postmenopausal hormone therapy and the risk of venous thrombosis: a population-based, case-control study. Br J Haematol 2013 0.77
210 Association between antibiotic use prior to breast cancer diagnosis and breast tumour characteristics (United States). Cancer Causes Control 2006 0.77
211 Post menopausal hormones and measures of subclinical atherosclerosis: the multi-ethnic study of atherosclerosis. Prev Med 2007 0.77
212 Serum lipoproteins in overweight/obese postmenopausal women: a one-year exercise trial. Med Sci Sports Exerc 2006 0.77
213 Completion of guideline-recommended initial evaluation of atrial fibrillation. Clin Cardiol 2012 0.77
214 Characteristics of study design and elements that may contribute to the success of electronic safety monitoring systems. Pharmacoepidemiol Drug Saf 2014 0.77
215 Long-term outcomes of left anterior fascicular block in the absence of overt cardiovascular disease. JAMA 2013 0.77
216 Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared to the General Population. J Acquir Immune Defic Syndr 2017 0.76
217 Hemodynamic fluid shear stress response genes and carotid intima-media thickness: a candidate gene association analysis in the cardiovascular health study. Int J Mol Epidemiol Genet 2012 0.76
218 Common genetic variation in the prothrombin gene, hormone therapy, and incident nonfatal myocardial infarction in postmenopausal women. Am J Epidemiol 2006 0.76
219 Replication and fine mapping of asthma-associated loci in individuals of African ancestry. Hum Genet 2013 0.76
220 Fraction of inspired oxygen in relation to cerebrospinal fluid hyperintensity on FLAIR MR imaging of the brain in children and young adults undergoing anesthesia. AJR Am J Roentgenol 2002 0.76
221 Red blood cell transfusion is associated with decreased in-hospital muscle strength among critically ill patients requiring mechanical ventilation. J Crit Care 2013 0.76
222 The cross-sectional association between vasomotor symptoms and hemostatic parameter levels in postmenopausal women. Menopause 2016 0.75
223 Long-term oral bisphosphonate use in relation to fracture risk in postmenopausal women with breast cancer: findings from the Women's Health Initiative. Menopause 2016 0.75
224 Obesity is associated with a lower resting oxygen saturation in the ambulatory elderly: results from the cardiovascular health study. Respir Care 2013 0.75
225 The association of F11 genetic variants with the risk of incident venous thrombosis among women, by statin use. Thromb Haemost 2015 0.75
226 Prior hysterectomy and oophorectomy and incident venous thrombosis risk among postmenopausal women: a population-based, case-control study. Menopause 2016 0.75
227 Multiethnic Exome-Wide Association Study of Subclinical Atherosclerosis. Circ Cardiovasc Genet 2016 0.75
228 Trial of lorcaserin for weight management. N Engl J Med 2010 0.75
229 Intensive glucose lowering and cardiovascular outcomes. N Engl J Med 2011 0.75
230 Erratum: Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation. Nat Genet 2017 0.75
231 Fifteen Genetic Loci Associated With the Electrocardiographic P Wave. Circ Cardiovasc Genet 2017 0.75
232 Risk factors for atrial fibrillation in a multi-center US clinical cohort of people with HIV infection. AIDS 2022 0.75
233 Risk of myocardial infarction attributable to elevated levels of total cholesterol among hypertensives. Am J Hypertens 2005 0.75
234 Erratum: Genetic loci associated with heart rate variability and their effects on cardiac disease risk. Nat Commun 2017 0.75
235 Serum potassium and stroke risk among treated hypertensive adults. Am J Hypertens 2003 0.75
236 Effect of progestogen and progestogen type on hemostasis measures in postmenopausal women: the Postmenopausal Estrogen/Progestin Intervention (PEPI) Study. Menopause 2009 0.75